Pharmaceutical Company Business Data Model | Capstera

The Pharmaceutical Company Business Data Model is a business data dictionary built for a typical pharmaceutical manufacturer — subject areas and data entities grouped into Foundational, Transactional, and Informational categories, each entity accompanied by a short description. It reads as a data glossary or business information model rather than a technical data model: it doesn't include entity-relationship mapping or a full attribute set for each entity.

It's aimed at data architects and business architects at pharmaceutical manufacturers who need a data entity inventory to start from instead of one to build from a blank page. Naming every entity a pharma business touches — across R&D, manufacturing, quality, and commercial functions — from scratch is slow work best done by editing something rather than inventing it.

A business data model is one of a handful of core business architecture artifacts, alongside capability maps and value streams. Cross-mapping the three shows which data actually supports which capability, which matters before a modernization or consolidation project gets underway.

The three categories sort the entity list by where the data comes from. Foundational data covers the core entities the business is organized around — the things that change rarely once established. Transactional data is generated by ongoing operations — the record of something that happened. Informational data is the processed, downstream form of the other two, shaped for reporting and decision-making rather than recording a single event. That structure is what makes the entity list function as a glossary rather than a loose collection of terms.

What's Inside

• Foundational data entities — the primary things the business is organized around
• Transactional data entities — the data generated by day-to-day operations
• Informational data entities — the processed, analyzed form used for reporting and decisions
• A short description for each data entity
• Not included: entity-relationship mapping or a full attribute list — this is a business-level dictionary, not a conventional data model

The purchase also bundles an extended set of business architecture reference files: templates for capability relationship mapping and capability assessment, an introduction to business capability modeling, a capabilities-to-microservices mapping example, and several guides on the business architecture practice, including a framework-to-enablement overview and a role/expectations guide for a business architecture leader.

How Teams Use It

A data architect at a pharmaceutical manufacturer cross-maps the entity list against manufacturing execution or quality systems ahead of a system consolidation project, treating the list as a checklist rather than a mystery to be solved from scratch. A business architect uses the model alongside the bundled capability guides to show operations leadership how the entities underpin specific capabilities, tying data back to what the business actually does. A quality or regulatory lead reviews the entity list as a starting inventory before formalizing a data governance program. An enterprise architecture team applies the included capability relationship mapping template to see where this data model overlaps with an existing capability map. A business architecture practice onboarding new architects uses the bundled capability modeling overview and framework materials as a shared reference point before assigning real project work.

Format & Delivery

The core data model is delivered as an editable Word document, with a Business Data Model Guide PDF and the extended bundle of bonus business architecture files described above. Checkout delivers the files immediately; enterprise licensing is available for team-wide use. The product is the entity dictionary and reference material; adding relationships, attributes, and company-specific detail remains your team's work.

Pharma companies differ significantly by therapeutic area, size, and regulatory scope, so expect to adjust the entity list — sometimes lightly, sometimes substantially — before it reflects your organization.